DA/K |
serum total cholesterol level |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 1;284(1):150-6. |
blood cholesterol amount |
female |
196 days-224 days |
12 |
serial mean |
115.83 |
mg/dl |
|
|
serum total cholesterol measurement test |
ophthalmic venous plexus |
|
0 |
Roche Cobas Mira Plus (Roche, Switzerland) |
average of measures taken at 196 days, 210 days and 224 days |
12426 |
251 |
MWF/FubRkb |
serum total cholesterol level |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
blood cholesterol amount |
not specified |
168 days
| 18 |
|
122.01 |
mg/dl |
6.95 |
29.49 |
serum total cholesterol measurement test |
|
0.0 |
0 |
serum triglyceride analysis |
|
65391 |
117 |
F344.OLETF-(D14Rat23-D14Rat12)/Tj |
serum total cholesterol level |
control condition |
Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22. |
blood cholesterol amount |
male |
168 days-175 days |
7 |
|
42.69 |
mg/dl |
5.25 |
13.89 |
serum total cholesterol measurement test |
|
0.0 |
0 |
T-CHO-E test kits, Wako Chem. Ltd. Osaka, Japan |
|
97747 |
1918 |
F344.ZUC-(Leprfa),OLETF-(D14Rat23-D14Rat12)/Tj |
serum total cholesterol level |
control condition |
Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22. |
blood cholesterol amount |
male |
168 days-175 days |
10 |
|
277.94 |
mg/dl |
40.79 |
128.99 |
serum total cholesterol measurement test |
|
0.0 |
0 |
T-CHO-E test kits, Wako Chem. Ltd. Osaka, Japan |
|
97749 |
1918 |
SHRSP/A3N |
serum total cholesterol level |
control condition |
Wexler BC, Stroke. 1980 Nov-Dec;11(6):665-71. doi: 10.1161/01.str.11.6.665. |
blood cholesterol amount |
male |
120 days-140 days |
24 |
|
87.0 |
mg/dl |
2.0 |
9.8 |
serum total cholesterol measurement test |
|
0.0 |
0 |
|
|
107624 |
3093 |
BN/Seac |
serum total cholesterol level |
control condition |
Asahina M, et al., J Lipid Res 2005 Aug 1 |
blood cholesterol amount |
male |
28 days
| 11 |
|
104.0 |
mg/dl |
3.1 |
10.28 |
serum total cholesterol measurement test |
|
|
0 |
Wako Pure Chemicals, Tokyo, Japan |
|
13138 |
71 |
SHRSP/A3 |
serum total cholesterol level |
control condition |
Kato N, et al., Arterioscler Thromb Vasc Biol 2000 Jan;20(1):223-9 |
blood cholesterol amount |
female |
112 days
| 5 |
|
55.72 |
mg/dl |
0.62 |
1.38 |
serum total cholesterol measurement test |
|
0.0 |
0 |
|
|
68956 |
1033 |
FHH-Nr4a1m1Mcwi |
serum total cholesterol level |
control condition |
Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10. |
blood cholesterol amount |
male |
56 days
| 6 |
|
71.0 |
mg/dl |
2.1 |
5.14 |
serum total cholesterol measurement test |
|
0.0 |
0 |
|
|
99502 |
2318 |
FHH-Nr4a1m1Mcwi |
serum total cholesterol level |
control condition |
Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10. |
blood cholesterol amount |
male |
112 days
| 6 |
|
122.0 |
mg/dl |
8.7 |
21.31 |
serum total cholesterol measurement test |
|
0.0 |
0 |
|
|
99504 |
2318 |
F344.OLETF-(D8Rat58-D8Mgh17)/Tj |
serum total cholesterol level |
control condition |
Kose H, et al., Exp Anim. 2008 Apr;57(2):135-8. |
blood cholesterol amount |
male |
217 days
| 20 |
|
59.7 |
mg/dl |
2.8 |
12.52 |
serum total cholesterol measurement test |
|
0 |
0 |
|
|
66181 |
716 |
SS/JrTol |
serum total cholesterol level |
control condition (for 140 days) |
Garrett MR, et al., Physiol Genomics. 2007 May 15;. |
blood cholesterol amount |
male |
140 days
| 6 |
|
114.9 |
mg/dl |
4.3 |
10.53 |
serum total cholesterol measurement test |
|
0.0 |
0 |
|
|
67975 |
834 |
F344.ZUC-Leprfa/Tj |
serum total cholesterol level |
control condition |
Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22. |
blood cholesterol amount |
male |
168 days-175 days |
10 |
|
426.24 |
mg/dl |
30.04 |
94.99 |
serum total cholesterol measurement test |
|
0.0 |
0 |
T-CHO-E test kits, Wako Chem. Ltd. Osaka, Japan |
|
97748 |
1918 |
SHR/NHsdMco |
serum total cholesterol level |
control condition (for 140 days) |
Garrett MR, et al., Physiol Genomics. 2007 May 15;. |
blood cholesterol amount |
male |
140 days
| 6 |
|
47.3 |
mg/dl |
7.6 |
18.62 |
serum total cholesterol measurement test |
|
0.0 |
0 |
|
|
67976 |
834 |
F344/NSlc |
serum total cholesterol level |
control condition |
Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22. |
blood cholesterol amount |
male |
168 days-175 days |
7 |
|
45.77 |
mg/dl |
4.03 |
10.66 |
serum total cholesterol measurement test |
|
0.0 |
0 |
T-CHO-E test kits, Wako Chem. Ltd. Osaka, Japan |
|
97746 |
1918 |
FHH/EurMcwi |
serum total cholesterol level |
control condition |
Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10. |
blood cholesterol amount |
male |
168 days
| 6 |
|
102.0 |
mg/dl |
9.7 |
23.76 |
serum total cholesterol measurement test |
|
0.0 |
0 |
|
|
99505 |
2318 |
FHH/EurMcwi |
serum total cholesterol level |
control condition |
Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10. |
blood cholesterol amount |
male |
56 days
| 6 |
|
70.0 |
mg/dl |
4.7 |
11.51 |
serum total cholesterol measurement test |
|
0.0 |
0 |
|
|
99501 |
2318 |
FHH/EurMcwi |
serum total cholesterol level |
control condition |
Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10. |
blood cholesterol amount |
male |
112 days
| 6 |
|
84.0 |
mg/dl |
7.9 |
19.35 |
serum total cholesterol measurement test |
|
0.0 |
0 |
|
|
99503 |
2318 |
FHH-Nr4a1m1Mcwi |
serum total cholesterol level |
control condition |
Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10. |
blood cholesterol amount |
male |
168 days
| 6 |
|
283.0 |
mg/dl |
29.4 |
72.01 |
serum total cholesterol measurement test |
|
0.0 |
0 |
|
|
99506 |
2318 |
ExHC/Seac |
serum total cholesterol level |
control condition |
Asahina M, et al., J Lipid Res 2005 Aug 1 |
blood cholesterol amount |
male |
28 days
| 7 |
|
84.0 |
mg/dl |
2.7 |
7.14 |
serum total cholesterol measurement test |
|
|
0 |
Wako Pure Chemicals, Tokyo, Japan |
|
13137 |
71 |
WOKW |
serum total cholesterol level |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 1;284(1):150-6. |
blood cholesterol amount |
female |
196 days-224 days |
12 |
serial mean |
84.94 |
mg/dl |
|
|
serum total cholesterol measurement test |
ophthalmic venous plexus |
|
0 |
Roche Cobas Mira Plus (Roche, Switzerland) |
average of measures taken at 196 days, 210 days and 224 days |
12425 |
251 |
SHRSP/A3 |
serum total cholesterol level |
control condition |
Kato N, et al., Arterioscler Thromb Vasc Biol 2000 Jan;20(1):223-9 |
blood cholesterol amount |
male |
112 days
| 5 |
|
50.22 |
mg/dl |
0.9 |
2.02 |
serum total cholesterol measurement test |
|
0.0 |
0 |
|
|
68955 |
1033 |
SS.SHR-(D2Rat61-D2Mco18)/Mco |
serum total cholesterol level |
control condition (for 140 days) |
Garrett MR, et al., Physiol Genomics. 2007 May 15;. |
blood cholesterol amount |
male |
140 days
| 6 |
|
97.3 |
mg/dl |
1.7 |
4.16 |
serum total cholesterol measurement test |
|
0.0 |
0 |
|
|
67977 |
834 |
F344.ZUC-Leprfa/Tj |
serum total cholesterol level |
control condition |
Kotoh J, et al., J Vet Med Sci. 2016 Aug 11. |
blood cholesterol amount |
male |
175 days
| 7 |
|
380.95 |
mg/dl |
26.3 |
69.58 |
serum total cholesterol measurement test |
|
0.0 |
0 |
T-Cho-E test kit (Wako Chem. LTD) |
|
98080 |
1978 |
MWF-Chr 6SHR/Rkb |
serum total cholesterol level |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
blood cholesterol amount |
not specified |
168 days
| 19 |
|
74.52 |
mg/dl |
2.32 |
10.1 |
serum total cholesterol measurement test |
|
0.0 |
0 |
serum triglyceride analysis |
|
65390 |
117 |
WKY/Izm |
serum total cholesterol level |
control condition |
Kato N, et al., Arterioscler Thromb Vasc Biol 2000 Jan;20(1):223-9 |
blood cholesterol amount |
male |
112 days
| 5 |
|
72.54 |
mg/dl |
1.54 |
3.45 |
serum total cholesterol measurement test |
|
0.0 |
0 |
|
some flavor of WKY |
68957 |
1033 |
F344/NSlc |
serum total cholesterol level |
control condition |
Kose H, et al., Exp Anim. 2008 Apr;57(2):135-8. |
blood cholesterol amount |
male |
217 days
| 9 |
|
52.4 |
mg/dl |
5.7 |
17.1 |
serum total cholesterol measurement test |
|
0 |
0 |
|
|
66180 |
716 |
SHR/FubRkb |
serum total cholesterol level |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
blood cholesterol amount |
not specified |
168 days
| 10 |
|
61.0 |
mg/dl |
1.93 |
6.1 |
serum total cholesterol measurement test |
|
0.0 |
0 |
serum triglyceride analysis |
|
65388 |
117 |
WKY/Izm |
serum total cholesterol level |
control condition |
Kato N, et al., Arterioscler Thromb Vasc Biol 2000 Jan;20(1):223-9 |
blood cholesterol amount |
female |
112 days
| 5 |
|
80.6 |
mg/dl |
2.45 |
5.48 |
serum total cholesterol measurement test |
|
0.0 |
0 |
|
some flavor of WKY |
68958 |
1033 |
F344.ZUC-(Leprfa),OLETF-(D5Rat166-D5Rat90)/Tj |
serum total cholesterol level |
control condition |
Kotoh J, et al., J Vet Med Sci. 2016 Aug 11. |
blood cholesterol amount |
male |
175 days
| 5 |
|
339.97 |
mg/dl |
29.35 |
65.63 |
serum total cholesterol measurement test |
|
0.0 |
0 |
T-Cho-E test kit (Wako Chem. LTD) |
|
98081 |
1978 |
SHRSP/A3N |
serum total cholesterol level |
control condition |
Wexler BC, Stroke. 1980 Nov-Dec;11(6):665-71. doi: 10.1161/01.str.11.6.665. |
blood cholesterol amount |
female |
120 days-140 days |
24 |
|
98.0 |
mg/dl |
1.0 |
4.9 |
serum total cholesterol measurement test |
|
0.0 |
0 |
|
|
107626 |
3093 |